Published in Women's Health Weekly, January 19th, 2006
"Bisphosphonates are potent inhibitors of osteoclast-mediated bone resorption," researchers in Australia explained. "Recent interest has centered on the effects of bisphosphonates on osteoblasts."
"Chronic dosing of osteoblasts with solubilized bisphosphonates has been reported to enhance osteogenesis and mineralization in vitro," noted A. Schindeler and colleagues at Children's Hospital Westmead in Sydney. "However, this methodology poorly reflects the in vivo situation, where free bisphosphonate becomes rapidly bound to mineralized bone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly